Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25502 | 21764223 | Med Hypotheses | Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. | 2011 | Details |
| A25503 | 21762556 | Respir Care | Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. | 2011 | Details |
| A25505 | 21760546 | J Pediatr Gastroenterol Nutr | Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. | 2012 | Details |
| A25508 | 21742296 | Clin Res Hepatol Gastroenterol | Liver fibrogenesis and metabolic factors. | 2011 | Details |
| A25510 | 21755261 | Braz J Med Biol Res | Effect of silybin on high-fat-induced fatty liver in rats. | 2011 | Details |
| A25517 | 21749681 | BMC Med | Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. | 2011 | Details |
| A25520 | 21748765 | Hepatology | Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. | 2011 | Details |
| A25523 | 21745307 | Liver Int | PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. | 2011 | Details |
| A25527 | 21745282 | Liver Int | The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. | 2011 | Details |
| A25528 | 21745271 | Liver Int | Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. | 2011 | Details |
| A25534 | 21738618 | PLoS One | Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. | 2011 | Details |
| A25538 | 21735081 | Dig Dis Sci | Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. | 2011 | Details |
| A25539 | 21734787 | World J Gastroenterol | Adiponectin, a key adipokine in obesity related liver diseases. | 2011 | Details |
| A25540 | 21734391 | Dig Dis | Pathophysiology of non-alcoholic steatohepatitis and basis for treatment. | 2011 | Details |
| A25543 | 21733326 | Br J Nutr | Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. | 2011 | Details |
| A25545 | 21727734 | Saudi J Gastroenterol | Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. | 2011 | Details |
| A25546 | 21727730 | Saudi J Gastroenterol | Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection. | 2011 | Details |
| A25550 | 21725512 | J Gastrointestin Liver Dis | Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). | 2011 | Details |
| A25551 | 21723839 | J Hepatol | Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. | 2011 | Details |
| A25552 | 21723084 | Presse Med | [Nonalcoholic fatty liver disease]. | 2011 | Details |
| A25553 | 21718726 | J Hepatol | Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. | 2011 | Details |
| A25554 | 21714459 | J Pediatr Endocrinol Metab | Relationship between aminotransferases levels and components of the metabolic syndrome among multiethnic adolescents. | 2010 | Details |
| A25562 | 21709958 | Arq Gastroenterol | Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in Wistar rats. | 2012 | Details |
| A25563 | 21708823 | Gut | Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. | 2011 | Details |
| A25565 | 21707532 | Mini Rev Med Chem | Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. | 2011 | Details |
| A25567 | 21704120 | Mol Cell Endocrinol | Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake. | 2011 | Details |
| A25569 | 21703998 | Gastroenterology | Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. | 2011 | Details |
| A25571 | 21703200 | J Hepatol | The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis. | 2011 | Details |
| A25573 | 21703181 | J Hepatol | Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. | 2011 | Details |
| A25577 | 21700865 | Science | Human fatty liver disease: old questions and new insights. | 2011 | Details |
| A25578 | 21697744 | J Pediatr Gastroenterol Nutr | Biochemical parameters and anthropometry predict NAFLD in obese children. | 2011 | Details |
| A25582 | 21690266 | J Lipid Res | Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. | 2011 | Details |
| A25594 | 21674556 | Hepatology | Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25602 | 21664213 | Clin Res Hepatol Gastroenterol | Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. | 2011 | Details |
| A25603 | 21663607 | Lipids Health Dis | Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. | 2011 | Details |
| A25607 | 21655948 | Dig Dis Sci | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. | 2011 | Details |
| A25608 | 21654360 | Adv Anat Pathol | Update on fatty liver disease and steatohepatitis. | 2011 | Details |
| A25609 | 21651352 | Expert Rev Gastroenterol Hepatol | Animal models in the study of hepatitis C virus-associated liver pathologies. | 2011 | Details |
| A25613 | 21645445 | Zhonghua Gan Zang Bing Za Zhi | [General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease]. | 2011 | Details |
| A25624 | 21633178 | J Clin Invest | The role of lipid droplets in metabolic disease in rodents and humans. | 2011 | Details |
| A25627 | 21629127 | J Pediatr Gastroenterol Nutr | Mechanisms of lipotoxicity in NAFLD and clinical implications. | 2011 | Details |
| A25641 | 21612059 | Vnitr Lek | [Steatosis and steatohepatitis in diabetic patient]. | 2011 | Details |
| A25642 | 21604917 | Ann Med | The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis. | 2011 | Details |
| A25647 | 21599535 | Crit Rev Biochem Mol Biol | Insulin signaling to hepatic lipid metabolism in health and disease. | 2011 | Details |
| A25650 | 21595271 | Nihon Rinsho | [Attenuation of fatty accumulation in hepatocyte by incretin--expectation of novel medicine for treatment of NASH]. | 2011 | Details |
| A25651 | 21593806 | Obesity (Silver Spring) | Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis. | 2011 | Details |
| A25653 | 21587068 | Curr Opin Clin Nutr Metab Care | The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. | 2011 | Details |
| A25655 | 21577310 | World J Gastrointest Pharmacol Ther | Is there any progress in the treatment of non-alcoholic fatty liver disease? | 2011 | Details |
| A25658 | 21570653 | Eur J Intern Med | Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome. | 2011 | Details |
| A25661 | 21569072 | Clin Endocrinol (Oxf) | Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. | 2011 | Details |
| A25664 | 21565756 | Orv Hetil | [Clinical correlations of chronic hepatitis C, diabetes mellitus and steatohepatitis]. | 2011 | Details |
| A25666 | 21564529 | Am J Transplant | Should metformin be our antiglycemic agent of choice post-transplantation? | 2011 | Details |
| A25671 | 21562784 | Dig Dis Sci | Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome. | 2011 | Details |
| A25672 | 21562757 | Diabetologia | Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. | 2011 | Details |
| A25673 | 21561340 | Metab Syndr Relat Disord | Oxidative stress is activated by free fatty acids in cultured human hepatocytes. | 2011 | Details |
| A25674 | 21561285 | Scand J Gastroenterol | Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men. | 2011 | Details |
| A25676 | 21559749 | Intern Emerg Med | Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? | 2011 | Details |
| A25680 | 21557024 | Hepatol Int | Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. | 2011 | Details |
| A25681 | 21556019 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. | 2011 | Details |
| A25682 | 21549692 | Eur J Pharmacol | Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. | 2011 | Details |
| A25683 | 21549113 | Eur J Pharmacol | Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. | 2011 | Details |
| A25684 | 21547049 | J Ayurveda Integr Med | A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. | 2010 | Details |
| A25686 | 21545576 | Br J Pharmacol | Resistin: functional roles and therapeutic considerations for cardiovascular disease. | 2012 | Details |
| A25687 | 21543214 | J Nutr Biochem | Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver. | 2011 | Details |
| A25691 | 21538280 | Semin Liver Dis | Genetics of alcoholic and nonalcoholic fatty liver disease. | 2011 | Details |
| A25695 | 21534339 | Turk J Pediatr | Abdominal obesity is an independent risk factor for increased carotid intima- media thickness in obese children. | 2011 | Details |
| A25699 | 21525818 | Med Sci Monit | SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. | 2011 | Details |
| A25702 | 21521338 | Clin Endocrinol (Oxf) | Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. | 2011 | Details |
| A25703 | 21521307 | Clin Endocrinol (Oxf) | Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. | 2011 | Details |
| A25711 | 21518734 | Arch Dis Child | Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. | 2011 | Details |
| A25719 | 21509233 | Sultan Qaboos Univ Med J | Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population. | 2010 | Details |
| A25722 | 21504583 | Lipids Health Dis | High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. | 2011 | Details |
| A25735 | 21495873 | Toxicol Mech Methods | Epigenetic priming of the metabolic syndrome. | 2011 | Details |
| A25736 | 21494075 | Korean J Hepatol | Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. | 2011 | Details |
| A25749 | 21484130 | Hepatol Int | Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate. | 2011 | Details |
| A25753 | 21479224 | PLoS One | Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. | 2011 | Details |
| A25756 | 21476922 | Expert Rev Gastroenterol Hepatol | Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? | 2011 | Details |
| A25757 | 21476921 | Expert Rev Gastroenterol Hepatol | Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis? | 2011 | Details |
| A25759 | 21476919 | Expert Rev Gastroenterol Hepatol | Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. | 2011 | Details |
| A25763 | 21476915 | Expert Rev Gastroenterol Hepatol | Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. | 2011 | Details |
| A25764 | 21476914 | Expert Rev Gastroenterol Hepatol | Inflammation in nonalcoholic steatohepatitis. | 2011 | Details |
| A25767 | 21476911 | Expert Rev Gastroenterol Hepatol | Autophagy in nonalcoholic steatohepatitis. | 2011 | Details |
| A25772 | 21475632 | Int J Gen Med | The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage. | 2011 | Details |
| A25776 | 21472332 | Mol Med Rep | Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease. | 2010 | Details |
| A25780 | 21463618 | Eur J Pharmacol | A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. | 2011 | Details |
| A25788 | 21455726 | Diabetologia | Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. | 2011 | Details |
| A25791 | 21452138 | Ther Umsch | [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. | 2011 | Details |
| A25794 | 21449949 | Diabetes Obes Metab | Current therapeutic strategies in non-alcoholic fatty liver disease. | 2011 | Details |
| A25797 | 22813407 | Diabetes Metab Syndr | Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population. | 2012 | Details |
| A25800 | 21446920 | Clin Sci (Lond) | Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine. | 2011 | Details |
| A25801 | 21445622 | Eur J Nutr | Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats. | 2011 | Details |
| A25805 | 21440669 | Clin Gastroenterol Hepatol | Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. | 2011 | Details |
| A25808 | 21439567 | Atherosclerosis | Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. | 2011 | Details |
| A25809 | 21438811 | Expert Rev Cardiovasc Ther | Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. | 2011 | Details |
| A25811 | 21436212 | J Renin Angiotensin Aldosterone Syst | Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25812 | 21436037 | Proc Natl Acad Sci U S A | Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. | 2011 | Details |
| A25814 | 21431854 | Curr Diab Rep | Why does NAFLD predict type 2 diabetes? | 2011 | Details |
| A25815 | 21430606 | Pol Arch Med Wewn | Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease. | 2011 | Details |
| A25818 | 21429628 | Gastroenterol Hepatol | [Non-alcoholic fatty liver disease. How and who to screen]. | 2011 | Details |
| A25821 | 21427524 | J Endocrinol Invest | Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? | 2011 | Details |